Figure 4.
The impact of TP53 mutation (A,B) and CDKN2A/MDM2/TP53 alterations (C,D) on overall survival (OS) (A,C) and disease-free survival (DFS) (B,D) in biliary tract cancers (BTCs). Data were accessed at cBioPortal on 3 September 2020.
Official websites use .gov
A
.gov website belongs to an official
government organization in the United States.
Secure .gov websites use HTTPS
A lock (
) or https:// means you've safely
connected to the .gov website. Share sensitive
information only on official, secure websites.